SVETLANA ROBINSON: Open Payments
NPI 1306312087 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,116 in 99 payments from 18 companies in 2025. Trend: 2023 $2,707 · 2024 $2,206 · 2025 $2,116
Food & beverage: $2,116
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $264 |
| Axsome Therapeutics, Inc. | 10 | $261 |
| Janssen Pharmaceuticals, Inc | 6 | $249 |
| Vanda Pharmaceuticals Inc. | 8 | $243 |
| ABBVIE INC. | 19 | $178 |
| Supernus Pharmaceuticals, Inc. | 12 | $163 |
| Otsuka America Pharmaceutical, Inc. | 10 | $159 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Lundbeck LLC | 5 | $116 |
| TMS NeuroHealth Centers Inc. | 2 | $86 |
Products named: REXULTI, CAPLYTA, Auvelity, SPRAVATO, VRAYLAR, Qelbree, FANAPT, COBENFY.
Industry payments across SC — which companies pay providers there.
